

| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 72.03 | 62.74 | 35.48 | 26.80 | 6.07 |
| Total Expenses | 68.15 | 60.25 | 34.35 | 26.51 | 5.91 |
| Profit Before Tax | 3.88 | 2.49 | 1.11 | 0.27 | 0.16 |
| Profit After Tax | 2.80 | 1.95 | 0.81 | 0.36 | 0.15 |
| Operating Profit After Depreciation | 4.17 | 3.16 | 1.92 | 0.77 | 0.34 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 10.65 | 10.20 | 10.13 | 2.01 | 1.70 |
| Total Non Current Assets | 12.93 | 12.53 | 10.71 | 9.27 | 3.22 |
| Total Current Assets | 34.45 | 24.63 | 23.59 | 18.82 | 14.78 |
| Total Assets | 47.39 | 37.17 | 34.30 | 28.09 | 18 |
| Total Shareholder's Fund | 16.56 | 14.18 | 11.72 | 10.99 | 4.78 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 4.06 | 5.35 | 1.10 | -1.08 | -0.31 |
| Net Cash Used In Investing Activities | -2.30 | -3.61 | -3.44 | -6.14 | -2.02 |
| Net Cash Used In Financing Activities | -0.68 | -1.77 | 2.42 | 6.71 | 2.95 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 60.26 | 51.44 | 28.97 | 26.80 | 6.07 |
| Total Expenses | 57.83 | 49.96 | 28.51 | 26.45 | 5.91 |
| Profit Before Tax | 2.43 | 1.48 | 0.46 | 0.34 | 0.16 |
| Profit After Tax | 1.69 | 1.11 | 0.29 | 0.42 | 0.15 |
| Operating Profit After Depreciation | 2.53 | 1.69 | 0.80 | 0.83 | 0.34 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 2.29 | 1.48 | 0.83 | 0.94 | 1.07 |
| Total Non Current Assets | 7.07 | 6.37 | 5.69 | 6.45 | 1.96 |
| Total Current Assets | 23.86 | 17.12 | 16.17 | 16.91 | 13.73 |
| Total Assets | 30.92 | 23.49 | 21.86 | 23.36 | 15.69 |
| Total Shareholder's Fund | 15.02 | 13.33 | 11.32 | 11.03 | 4.78 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 2.71 | 3.13 | 1.09 | -0.32 | 1.38 |
| Net Cash Used In Investing Activities | -1.23 | -0.88 | 0.46 | -4.58 | -0.70 |
| Net Cash Used In Financing Activities | -0.42 | -2.18 | -1.52 | 4.27 | -0.06 |
No data available
No data available
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,763.70 | ₹4,23,170.71 |
| Divis Laboratories Ltd | ₹6,523.25 | ₹1,73,171.79 |
| Torrent Pharmaceuticals Ltd | ₹3,816.75 | ₹1,29,170.36 |
| Cipla Ltd | ₹1,536.25 | ₹1,24,093.85 |
| Dr Reddys Laboratories Ltd | ₹1,244.50 | ₹1,03,868.61 |
No data available
On 13 November 2025
10 Nov 2025, 06:27 pm
On 25 September 2025
08 Sep 2025, 02:41 pm
On 15 May 2025
13 May 2025, 04:54 pm

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Congratulations,
Your Digital savings bank account opening journey is complete.